TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs968722
log Bayes Factor = 9.57289
Chromosome 6   position 28,949,904  (GRCh37) Explore rs968722 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40 Psoriasis
0.999 0.001 0.000
L40.5 Arthropathic psoriasis
0.997 0.003 0.000
K90.0 Coeliac disease
0.000 0.038 0.962
L40.0 Psoriasis vulgaris
0.959 0.041 0.000
E03.9 Hypothyroidism, unspecified
0.000 0.050 0.950
E03 Other hypothyroidism
0.000 0.115 0.885
E00-E07 Disorders of thyroid gland
0.000 0.157 0.843
L40.4 Guttate psoriasis
0.828 0.172 0.000
E06 Thyroiditis
0.000 0.234 0.766
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.247 0.753
E06.3 Autoimmune thyroiditis
0.000 0.272 0.728
K90 Intestinal malabsorption
0.000 0.272 0.728
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.274 0.726
L40.3 Pustulosis palmaris et plantaris
0.716 0.284 0.000
L40.2 Acrodermatitis continua
0.716 0.284 0.000
L40.1 Generalised pustular psoriasis
0.716 0.284 0.000
E83.1 Disorders of iron metabolism
0.000 0.295 0.705
E20-E35 Disorders of other endocrine glands
0.000 0.297 0.703
E27 Other disorders of adrenal gland
0.000 0.303 0.697
E83 Disorders of mineral metabolism
0.000 0.310 0.690
E27.1 Primary adrenocortical insufficiency
0.000 0.311 0.689
E70-E90 Metabolic disorders
0.000 0.314 0.686
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.315 0.685
K90.9 Intestinal malabsorption, unspecified
0.000 0.327 0.673
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.338 0.662
L40.8 Other psoriasis
0.642 0.358 0.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.360 0.640
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.360 0.640
E03.5 Myxoedema coma
0.000 0.366 0.634
E03.4 Atrophy of thyroid (acquired)
0.000 0.366 0.634
E03.3 Postinfectious hypothyroidism
0.000 0.366 0.634
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.366 0.634
E10-E14 Diabetes mellitus
0.000 0.383 0.617
E80.4 Gilbert's syndrome
0.000 0.387 0.613
E07 Other disorders of thyroid
0.000 0.388 0.612
E29 Testicular dysfunction
0.000 0.391 0.609
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.396 0.604
E00 Congenital iodine-deficiency syndrome
0.000 0.396 0.604
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.396 0.604
E10 Insulin-dependent diabetes mellitus
0.000 0.396 0.604
E03.8 Other specified hypothyroidism
0.000 0.398 0.602
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.424 0.576
E03.1 Congenital hypothyroidism without goitre
0.000 0.424 0.576
E20 Hypoparathyroidism
0.000 0.425 0.575
E10.9 Without complications
0.000 0.434 0.566
E06.5 Other chronic thyroiditis
0.000 0.451 0.549
E06.4 Drug-induced thyroiditis
0.000 0.451 0.549
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.451 0.549
E06.1 Subacute thyroiditis
0.000 0.451 0.549
E06.0 Acute thyroiditis
0.000 0.451 0.549
E27.8 Other specified disorders of adrenal gland
0.000 0.452 0.548
E10.1 With ketoacidosis
0.000 0.453 0.547
E27.2 Addisonian crisis
0.000 0.453 0.547
E34 Other endocrine disorders
0.000 0.458 0.542
E29.1 Testicular hypofunction
0.000 0.459 0.541
E05.5 Thyroid crisis or storm
0.000 0.460 0.540
E05.4 Thyrotoxicosis factitia
0.000 0.460 0.540
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.460 0.540
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.460 0.540
E05.8 Other thyrotoxicosis
0.000 0.470 0.529
K90.3 Pancreatic steatorrhoea
0.000 0.478 0.522
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.478 0.522
K90.1 Tropical sprue
0.000 0.478 0.522
E83.4 Disorders of magnesium metabolism
0.000 0.485 0.514
E27.9 Disorder of adrenal gland, unspecified
0.000 0.493 0.507
E10.8 With unspecified complications
0.000 0.494 0.506
E83.3 Disorders of phosphorus metabolism
0.000 0.494 0.506
E23 Hypofunction and other disorders of pituitary gland
0.000 0.495 0.505
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.496 0.504
E32 Diseases of thymus
0.000 0.496 0.504
E31 Polyglandular dysfunction
0.000 0.496 0.504
E30 Disorders of puberty, not elsewhere classified
0.000 0.496 0.504
E25 Adrenogenital disorders
0.000 0.496 0.504
E22 Hyperfunction of pituitary gland
0.000 0.499 0.501
E27.5 Adrenomedullary hyperfunction
0.000 0.500 0.500
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.500 0.500
E27.0 Other adrenocortical overactivity
0.000 0.500 0.500
E07.9 Disorder of thyroid, unspecified
0.000 0.503 0.497
E10.2 With renal complications
0.000 0.504 0.496
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.506 0.494
E83.8 Other disorders of mineral metabolism
0.000 0.506 0.494
E83.2 Disorders of zinc metabolism
0.000 0.506 0.494
E83.0 Disorders of copper metabolism
0.000 0.506 0.494
E73 Lactose intolerance
0.000 0.506 0.494
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.507 0.493
E84 Cystic fibrosis
0.000 0.508 0.492
E79 Disorders of purine and pyrimidine metabolism
0.000 0.508 0.492
E77 Disorders of glycoprotein metabolism
0.000 0.508 0.492
E76 Disorders of glycosaminoglycan metabolism
0.000 0.508 0.492
E72 Other disorders of amino-acid metabolism
0.000 0.508 0.492
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.508 0.492
E70 Disorders of aromatic amino-acid metabolism
0.000 0.508 0.492
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.508 0.492
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.517 0.483
E20.9 Hypoparathyroidism, unspecified
0.000 0.517 0.483
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.530 0.470
E74 Other disorders of carbohydrate metabolism
0.000 0.531 0.469
E80.6 Other disorders of bilirubin metabolism
0.000 0.533 0.467
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.541 0.459
E80.5 Crigler-Najjar syndrome
0.000 0.541 0.459
E80.3 Defects of catalase and peroxydase
0.000 0.541 0.459
E80.1 Porphyria cutanea tarda
0.000 0.541 0.459
E80.0 Hereditary erythropoietic porphyria
0.000 0.541 0.459
K90.8 Other intestinal malabsorption
0.000 0.545 0.455
E06.9 Thyroiditis, unspecified
0.000 0.548 0.452
E12 Malnutrition-related diabetes mellitus
0.000 0.558 0.442
E07.1 Dyshormogenetic goitre
0.000 0.561 0.439
E07.0 Hypersecretion of calcitonin
0.000 0.561 0.439
E10.3 With ophthalmic complications
0.000 0.561 0.439
E85 Amyloidosis
0.000 0.561 0.438
E14 Unspecified diabetes mellitus
0.000 0.563 0.437
E29.9 Testicular dysfunction, unspecified
0.000 0.563 0.436
E29.8 Other testicular dysfunction
0.000 0.563 0.436
E29.0 Testicular hyperfunction
0.000 0.563 0.436
E34.0 Carcinoid syndrome
0.000 0.564 0.436
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.567 0.433
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.567 0.433
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.567 0.433
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.567 0.433
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.567 0.433
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.567 0.433
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.567 0.433
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.567 0.433
E10.7 With multiple complications
0.000 0.567 0.433
E10.0 With coma
0.000 0.569 0.431
E26 Hyperaldosteronism
0.000 0.571 0.429
E88 Other metabolic disorders
0.000 0.582 0.417
E24 Cushing's syndrome
0.000 0.584 0.415
E40-E46 Malnutrition
0.000 0.585 0.414
E14.3 With ophthalmic complications
0.000 0.587 0.413
E20.8 Other hypoparathyroidism
0.000 0.588 0.412
E20.1 Pseudohypoparathyroidism
0.000 0.588 0.412
E20.0 Idiopathic hypoparathyroidism
0.000 0.588 0.412
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.590 0.410
E22.1 Hyperprolactinaemia
0.000 0.593 0.407
E80.2 Other porphyria
0.000 0.594 0.406
E34.8 Other specified endocrine disorders
0.000 0.600 0.399
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.605 0.395
E34.5 Androgen resistance syndrome
0.000 0.611 0.388
E34.4 Constitutional tall stature
0.000 0.611 0.388
E34.3 Short stature, not elsewhere classified
0.000 0.611 0.388
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.611 0.388
E34.1 Other hypersecretion of intestinal hormones
0.000 0.611 0.388
E10.4 With neurological complications
0.000 0.615 0.385
E10.5 With peripheral circulatory complications
0.000 0.616 0.384
E23.7 Disorder of pituitary gland, unspecified
0.000 0.617 0.382
E86 Volume depletion
0.000 0.619 0.381
E23.0 Hypopituitarism
0.000 0.629 0.370
E07.8 Other specified disorders of thyroid
0.000 0.636 0.364
E22.0 Acromegaly and pituitary gigantism
0.000 0.637 0.363
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.638 0.362
E23.1 Drug-induced hypopituitarism
0.000 0.638 0.362
E34.9 Endocrine disorder, unspecified
0.000 0.638 0.362
E25.9 Adrenogenital disorder, unspecified
0.000 0.638 0.361
E25.8 Other adrenogenital disorders
0.000 0.638 0.361
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.638 0.361
E30.9 Disorder of puberty, unspecified
0.000 0.638 0.361
E30.8 Other disorders of puberty
0.000 0.638 0.361
E30.1 Precocious puberty
0.000 0.638 0.361
E30.0 Delayed puberty
0.000 0.638 0.361
E31.9 Polyglandular dysfunction, unspecified
0.000 0.638 0.361
E31.8 Other polyglandular dysfunction
0.000 0.638 0.361
E31.1 Polyglandular hyperfunction
0.000 0.638 0.361
E31.0 Autoimmune polyglandular failure
0.000 0.638 0.361
E32.9 Disease of thymus, unspecified
0.000 0.638 0.361
E32.8 Other diseases of thymus
0.000 0.638 0.361
E32.1 Abscess of thymus
0.000 0.638 0.361
E32.0 Persistent hyperplasia of thymus
0.000 0.638 0.361
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.638 0.361
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.638 0.361
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.638 0.361
E10.6 With other specified complications
0.000 0.640 0.360
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.641 0.359
E22.8 Other hyperfunction of pituitary gland
0.000 0.641 0.359
E65-E68 Obesity and other hyperalimentation
0.000 0.643 0.357
E73.9 Lactose intolerance, unspecified
0.000 0.644 0.356
E73.8 Other lactose intolerance
0.000 0.646 0.354
E73.1 Secondary lactase deficiency
0.000 0.646 0.354
E73.0 Congenital lactase deficiency
0.000 0.646 0.354
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.647 0.353
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.647 0.353
E70.3 Albinism
0.000 0.647 0.353
E70.2 Disorders of tyrosine metabolism
0.000 0.647 0.353
E70.1 Other hyperphenylalaninaemias
0.000 0.647 0.353
E70.0 Classical phenylketonuria
0.000 0.647 0.353
E71.3 Disorders of fatty-acid metabolism
0.000 0.647 0.353
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.647 0.353
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.647 0.353
E71.0 Maple-syrup-urine disease
0.000 0.647 0.353
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.647 0.353
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.647 0.353
E72.5 Disorders of glycine metabolism
0.000 0.647 0.353
E72.4 Disorders of ornithine metabolism
0.000 0.647 0.353
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.647 0.353
E72.2 Disorders of urea cycle metabolism
0.000 0.647 0.353
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.647 0.353
E72.0 Disorders of amino-acid transport
0.000 0.647 0.353
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.647 0.353
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.647 0.353
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.647 0.353
E76.2 Other mucopolysaccharidoses
0.000 0.647 0.353
E76.1 Mucopolysaccharidosis, type II
0.000 0.647 0.353
E76.0 Mucopolysaccharidosis, type I
0.000 0.647 0.353
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.647 0.353
E77.8 Other disorders of glycoprotein metabolism
0.000 0.647 0.353
E77.1 Defects in glycoprotein degradation
0.000 0.647 0.353
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.647 0.353
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.647 0.353
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.647 0.353
E79.1 Lesch-Nyhan syndrome
0.000 0.647 0.353
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.647 0.353
E84.9 Cystic fibrosis, unspecified
0.000 0.647 0.353
E84.8 Cystic fibrosis with other manifestations
0.000 0.647 0.353
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.647 0.353
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.647 0.353
E13 Other specified diabetes mellitus
0.000 0.647 0.352
E23.2 Diabetes insipidus
0.000 0.650 0.350
E89.3 Postprocedural hypopituitarism
0.000 0.652 0.348
E23.6 Other disorders of pituitary gland
0.000 0.657 0.343
E75.6 Lipid storage disorder, unspecified
0.000 0.663 0.337
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.663 0.337
E75.3 Sphingolipidosis, unspecified
0.000 0.663 0.337
E75.2 Other sphingolipidosis
0.000 0.663 0.337
E75.1 Other gangliosidosis
0.000 0.663 0.337
E75.0 GM2 gangliosidosis
0.000 0.663 0.337
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.664 0.336
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.664 0.336
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.664 0.336
E74.2 Disorders of galactose metabolism
0.000 0.664 0.336
E74.1 Disorders of fructose metabolism
0.000 0.664 0.336
E74.0 Glycogen storage disease
0.000 0.664 0.336
E28 Ovarian dysfunction
0.000 0.665 0.335
E88.2 Lipomatosis, not elsewhere classified
0.000 0.673 0.326
E85.3 Secondary systemic amyloidosis
0.000 0.676 0.324
E14.8 With unspecified complications
0.000 0.680 0.320
E12.9 Without complications
0.000 0.683 0.317
E12.8 With unspecified complications
0.000 0.683 0.317
E12.7 With multiple complications
0.000 0.683 0.317
E12.6 With other specified complications
0.000 0.683 0.317
E12.5 With peripheral circulatory complications
0.000 0.683 0.317
E12.4 With neurological complications
0.000 0.683 0.317
E12.3 With ophthalmic complications
0.000 0.683 0.317
E12.2 With renal complications
0.000 0.683 0.317
E12.1 With ketoacidosis
0.000 0.683 0.317
E12.0 With coma
0.000 0.683 0.317
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.684 0.316
E75.5 Other lipid storage disorders
0.000 0.685 0.314
E85.8 Other amyloidosis
0.000 0.685 0.314
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.685 0.314
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.685 0.314
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.685 0.314
E14.7 With multiple complications
0.000 0.686 0.314
E14.2 Withrenal complications
0.000 0.686 0.314
E14.0 With coma
0.000 0.686 0.314
E04 Other non-toxic goitre
0.000 0.687 0.313
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.687 0.313
E26.9 Hyperaldosteronism, unspecified
0.000 0.692 0.307
E26.8 Other hyperaldosteronism
0.000 0.692 0.307
E26.1 Secondary hyperaldosteronism
0.000 0.692 0.307
E85.9 Amyloidosis, unspecified
0.000 0.696 0.304
E88.9 Metabolic disorder, unspecified
0.000 0.700 0.299
E88.3 Tumour lysis syndrome
0.000 0.700 0.299
E24.8 Other Cushing's syndrome
0.000 0.702 0.298
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.702 0.298
E24.3 Ectopic ACTH syndrome
0.000 0.702 0.298
E24.2 Drug-induced Cushing's syndrome
0.000 0.702 0.298
E24.1 Nelson's syndrome
0.000 0.702 0.298
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.703 0.297
E45 Retarded development following protein-energy malnutrition
0.000 0.703 0.297
E43 Unspecified severe protein-energy malnutrition
0.000 0.703 0.297
E42 Marasmic kwashiorkor
0.000 0.703 0.297
E41 Nutritional marasmus
0.000 0.703 0.297
E40 Kwashiorkor
0.000 0.703 0.297
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.706 0.294
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.706 0.294
E89.5 Postprocedural testicular hypofunction
0.000 0.706 0.294
E89.1 Postprocedural hypoinsulinaemia
0.000 0.706 0.294
E14.4 With neurological complications
0.000 0.713 0.287
E89.4 Postprocedural ovarian failure
0.000 0.714 0.285
E15 Nondiabetic hypoglycaemic coma
0.000 0.717 0.283
E88.8 Other specified metabolic disorders
0.000 0.718 0.282
E24.0 Pituitary-dependent Cushing's disease
0.000 0.724 0.275
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.726 0.273
E14.6 With other specified complications
0.000 0.731 0.268
E65 Localised adiposity
0.000 0.733 0.267
E14.5 With peripheral circulatory complications
0.000 0.735 0.264
E50-E64 Other nutritional deficiencies
0.000 0.737 0.263
E14.1 With ketoacidosis
0.000 0.737 0.263
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.738 0.261
E85.4 Organ-limited amyloidosis
0.000 0.739 0.261
E67 Other hyperalimentation
0.000 0.744 0.256
E68 Sequelae of hyperalimentation
0.000 0.744 0.256
L40-L45 Papulosquamous disorders
0.255 0.745 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.747 0.253
E13.8 With unspecified complications
0.000 0.747 0.253
E13.7 With multiple complications
0.000 0.747 0.253
E13.6 With other specified complications
0.000 0.747 0.253
E13.5 With peripheral circulatory complications
0.000 0.747 0.253
E13.4 With neurological complications
0.000 0.747 0.253
E13.3 With ophthalmic complications
0.000 0.747 0.253
E13.2 With renal complications
0.000 0.747 0.253
E13.1 With ketoacidosis
0.000 0.747 0.253
E13.0 With coma
0.000 0.747 0.253
E89.2 Postprocedural hypoparathyroidism
0.000 0.749 0.251
E24.9 Cushing's syndrome, unspecified
0.000 0.758 0.242
E28.9 Ovarian dysfunction, unspecified
0.000 0.759 0.240
E28.8 Other ovarian dysfunction
0.000 0.759 0.240
E28.1 Androgen excess
0.000 0.759 0.240
E28.0 Oestrogen excess
0.000 0.759 0.240
E26.0 Primary hyperaldosteronism
0.000 0.767 0.232
E14.9 Without complications
0.000 0.772 0.228
E04.8 Other specified non-toxic goitre
0.000 0.775 0.225
E04.9 Non-toxic goitre, unspecified
0.000 0.776 0.224
E83.5 Disorders of calcium metabolism
0.000 0.776 0.224
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.778 0.222
E04.0 Non-toxic diffuse goitre
0.000 0.781 0.219
E44.1 Mild protein-energy malnutrition
0.000 0.787 0.213
E44.0 Moderate protein-energy malnutrition
0.000 0.787 0.213
E28.3 Primary ovarian failure
0.000 0.797 0.202
E46 Unspecified protein-energy malnutrition
0.000 0.809 0.191
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.811 0.189
E63 Other nutritional deficiencies
0.000 0.811 0.189
E51 Thiamine deficiency
0.000 0.811 0.189
E50 Vitamin A deficiency
0.000 0.811 0.189
E60 Dietary zinc deficiency
0.000 0.811 0.189
E59 Dietary selenium deficiency
0.000 0.811 0.189
E54 Ascorbic acid deficiency
0.000 0.811 0.189
E52 Niacin deficiency [pellagra]
0.000 0.811 0.189
E67.8 Other specified hyperalimentation
0.000 0.816 0.184
E67.3 Hypervitaminosis D
0.000 0.816 0.184
E67.2 Megavitamin-B6 syndrome
0.000 0.816 0.184
E67.1 Hypercarotenaemia
0.000 0.816 0.184
E67.0 Hypervitaminosis A
0.000 0.816 0.184
L44 Other papulosquamous disorders
0.183 0.817 0.000
L41 Parapsoriasis
0.183 0.817 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.183 0.817 0.000
L42 Pityriasis rosea
0.183 0.817 0.000
E56 Other vitamin deficiencies
0.000 0.823 0.177
E61 Deficiency of other nutrient elements
0.000 0.828 0.172
E04.2 Non-toxic multinodular goitre
0.000 0.828 0.172
E58 Dietary calcium deficiency
0.000 0.831 0.168
E13.9 Without complications
0.000 0.837 0.163
E21.4 Other specified disorders of parathyroid gland
0.000 0.840 0.159
E21.2 Other hyperparathyroidism
0.000 0.840 0.159
E16 Other disorders of pancreatic internal secretion
0.000 0.842 0.157
E53 Deficiency of other B group vitamins
0.000 0.845 0.155
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.848 0.151
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.852 0.148
E28.2 Polycystic ovarian syndrome
0.000 0.854 0.146
E55 Vitamin D deficiency
0.000 0.863 0.137
E50.9 Vitamin A deficiency, unspecified
0.000 0.864 0.135
E50.8 Other manifestations of vitamin A deficiency
0.000 0.864 0.135
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.864 0.135
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.864 0.135
E50.5 Vitamin A deficiency with night blindness
0.000 0.864 0.135
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.864 0.135
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.864 0.135
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.864 0.135
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.864 0.135
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.864 0.135
E51.9 Thiamine deficiency, unspecified
0.000 0.864 0.135
E51.8 Other manifestations of thiamine deficiency
0.000 0.864 0.135
E51.2 Wernicke's encephalopathy
0.000 0.864 0.135
E51.1 Beriberi
0.000 0.864 0.135
E63.9 Nutritional deficiency, unspecified
0.000 0.864 0.135
E63.8 Other specified nutritional deficiencies
0.000 0.864 0.135
E63.1 Imbalance of constituents of food intake
0.000 0.864 0.135
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.864 0.135
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.864 0.135
E64.8 Sequelae of other nutritional deficiencies
0.000 0.864 0.135
E64.3 Sequelae of rickets
0.000 0.864 0.135
E64.2 Sequelae of vitamin C deficiency
0.000 0.864 0.135
E64.1 Sequelae of vitamin A deficiency
0.000 0.864 0.135
E64.0 Sequelae of protein-energy malnutrition
0.000 0.864 0.135
L41.9 Parapsoriasis, unspecified
0.131 0.868 0.000
L41.8 Other parapsoriasis
0.131 0.868 0.000
L41.5 Retiform parapsoriasis
0.131 0.868 0.000
L41.4 Large plaque parapsoriasis
0.131 0.868 0.000
L41.3 Small plaque parapsoriasis
0.131 0.868 0.000
L41.2 Lymphomatoid papulosis
0.131 0.868 0.000
L41.1 Pityriasis lichenoides chronica
0.131 0.868 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.131 0.868 0.000
L44.9 Papulosquamous disorder, unspecified
0.131 0.868 0.000
L44.8 Other specified papulosquamous disorders
0.131 0.868 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.131 0.868 0.000
L44.3 Lichen ruber moniliformis
0.131 0.868 0.000
L44.2 Lichen striatus
0.131 0.868 0.000
L44.1 Lichen nitidus
0.131 0.868 0.000
L44.0 Pityriasis rubra pilaris
0.131 0.868 0.000
E56.9 Vitamin deficiency, unspecified
0.000 0.873 0.127
E56.8 Deficiency of other vitamins
0.000 0.873 0.127
E56.0 Deficiency of vitamin E
0.000 0.873 0.127
E61.9 Deficiency of nutrient element, unspecified
0.000 0.877 0.123
E61.8 Deficiency of other specified nutrient elements
0.000 0.877 0.123
E61.7 Deficiency of multiple nutrient elements
0.000 0.877 0.123
E61.6 Vanadium deficiency
0.000 0.877 0.123
E61.5 Molybdenum deficiency
0.000 0.877 0.123
E61.4 Chromium deficiency
0.000 0.877 0.123
E61.3 Manganese deficiency
0.000 0.877 0.123
E61.2 Magnesium deficiency
0.000 0.877 0.123
E61.0 Copper deficiency
0.000 0.877 0.123
E56.1 Deficiency of vitamin K
0.000 0.884 0.115
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.887 0.113
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.887 0.113
E16.4 Abnormal secretion of gastrin
0.000 0.887 0.113
E16.3 Increased secretion of glucagon
0.000 0.887 0.113
E53.9 Vitamin B deficiency, unspecified
0.000 0.888 0.111
E53.1 Pyridoxine deficiency
0.000 0.888 0.111
E53.0 Riboflavin deficiency
0.000 0.888 0.111
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.889 0.111
E61.1 Iron deficiency
0.000 0.894 0.106
L43 Lichen planus
0.103 0.897 0.000
E55.0 Rickets, active
0.000 0.902 0.098
E89.0 Postprocedural hypothyroidism
0.000 0.903 0.097
E21.3 Hyperparathyroidism, unspecified
0.000 0.905 0.095
E04.1 Non-toxic single thyroid nodule
0.000 0.906 0.094
E21.0 Primary hyperparathyroidism
0.000 0.906 0.094
K90-K93 Other diseases of the digestive system
0.000 0.910 0.090
E16.1 Other hypoglycaemia
0.000 0.910 0.089
E53.8 Deficiency of other specified B group vitamins
0.000 0.922 0.078
L43.3 Subacute (active) lichen planus
0.074 0.926 0.000
L43.2 Lichenoid drug reaction
0.074 0.926 0.000
L43.1 Bullous lichen planus
0.074 0.926 0.000
L43.0 Hypertrophic lichen planus
0.074 0.926 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.935 0.065
E66 Obesity
0.000 0.939 0.061
L43.8 Other lichen planus
0.053 0.947 0.001
E16.2 Hypoglycaemia, unspecified
0.000 0.948 0.052
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.950 0.050
E66.0 Obesity due to excess calories
0.000 0.951 0.049
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.953 0.047
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.953 0.047
K93.1 Megacolon in Chagas' disease
0.000 0.953 0.047
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.953 0.047
E55.9 Vitamin D deficiency, unspecified
0.000 0.954 0.046
E66.1 Drug-induced obesity
0.000 0.956 0.044
E78.8 Other disorders of lipoprotein metabolism
0.000 0.957 0.043
L43.9 Lichen planus, unspecified
0.040 0.960 0.000
K91.4 Colostomy and enterostomy malfunction
0.000 0.960 0.040
E78.1 Pure hyperglyceridaemia
0.000 0.962 0.038
E78.6 Lipoprotein deficiency
0.000 0.964 0.036
E78.3 Hyperchylomicronaemia
0.000 0.964 0.036
K91.3 Postoperative intestinal obstruction
0.000 0.964 0.036
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.965 0.035
K91.5 Postcholecystectomy syndrome
0.000 0.965 0.035
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.967 0.033
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.969 0.031
E78.4 Other hyperlipidaemia
0.000 0.970 0.030
K91.1 Postgastric surgery syndromes
0.000 0.971 0.028
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.973 0.026
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.974 0.025
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.979 0.021
K01.1 Impacted teeth
0.000 0.979 0.021
T92.2 Sequelae of fracture at wrist and hand level
0.020 0.980 0.000
T92 Sequelae of injuries of upper limb
0.019 0.981 0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb
0.019 0.981 0.000
T92.1 Sequelae of fracture of arm
0.017 0.983 0.000
T92.8 Sequelae of other specified injuries of upper limb
0.017 0.983 0.000
T92.0 Sequelae of open wound of upper limb
0.016 0.984 0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb
0.016 0.984 0.000
T92.4 Sequelae of injury of nerve of upper limb
0.014 0.985 0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb
0.013 0.986 0.000
K92 Other diseases of digestive system
0.000 0.987 0.013
E78.2 Mixed hyperlipidaemia
0.002 0.988 0.011
K92.9 Disease of digestive system, unspecified
0.000 0.988 0.012
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.012 0.988 0.000
T92.9 Sequelae of unspecified injury of upper limb
0.011 0.989 0.000
M35.0 Sicca syndrome [Sjogren]
0.000 0.989 0.011
G40 Epilepsy
0.011 0.989 0.000
E66.8 Other obesity
0.000 0.989 0.011
G40.3 Generalised idiopathic epilepsy and epileptic syndromes
0.011 0.989 0.000
S02.20 Fracture of nasal bones (closed)
0.010 0.990 0.000
K92.8 Other specified diseases of digestive system
0.000 0.990 0.010
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.010 0.990 0.000
S62.30 Fracture of other metacarpal bone (closed)
0.009 0.991 0.000
M47.82 Other spondylosis (Cervical region)
0.009 0.991 0.000
K01 Embedded and impacted teeth
0.000 0.991 0.009
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.009 0.991 0.000
J35.0 Chronic tonsillitis
0.000 0.991 0.009
G40.4 Other generalised epilepsy and epileptic syndromes
0.009 0.991 0.000
G40.7 Petit mal, unspecified, without grand mal seizures
0.008 0.992 0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.008 0.992 0.000
G40.5 Special epileptic syndromes
0.008 0.992 0.000
B18.2 Chronic viral hepatitis C
0.008 0.992 0.000
S02.2 Fracture of nasal bones
0.007 0.992 0.000
G40.8 Other epilepsy
0.007 0.993 0.000
K01.0 Embedded teeth
0.000 0.993 0.007
G40.9 Epilepsy, unspecified
0.007 0.993 0.000
Q61.3 Polycystic kidney, unspecified
0.007 0.993 0.000
R01.1 Cardiac murmur, unspecified
0.006 0.994 0.000
M47.89 Other spondylosis (Site unspecified)
0.006 0.994 0.000
M35 Other systemic involvement of connective tissue
0.000 0.994 0.006
F05.9 Delirium, unspecified
0.000 0.994 0.006
M47.8 Other spondylosis
0.006 0.994 0.000
S02.40 Fracture of malar and maxillary bones (closed)
0.006 0.994 0.000
B18 Chronic viral hepatitis
0.006 0.994 0.000
S02.21 Fracture of nasal bones (open)
0.005 0.994 0.000
M35.3 Polymyalgia rheumatica
0.000 0.994 0.006
K60.1 Chronic anal fissure
0.006 0.994 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.